Announcement • Nov 28
Royal Road Minerals Limited announced that it has received CAD 4.999054 million in funding from Rio2 Limited and other investors On November 27, 2025. Royal Road Minerals Limited closed the transaction. The company issued 27,772,523 ordinary shares at a price of CAD 0.18 per Share, for gross proceeds of up to CAD 4,999,054.14. The transaction included participation from returning investor Rio2 Limited for 4,166,667 ordinary shares to maintain its approximately 15% equity stake. In connection with the closing of the Offering, the Company paid certain eligible persons cash commissions in the aggregate amount of CAD 251,319.23 and issued an aggregate of 1,396,215 broker warrants (each, a “Broker Warrant”). Each Broker Warrant entitles the holder thereof to acquire one Share at a price of CAD 0.18 per Share for a period of thirty-six (36) months from the closing of the Offering. Announcement • Nov 04
Royal Road Minerals Limited announced that it expects to receive CAD 5 million in funding Royal Road Minerals Limited announced a non-brokered private placement offering of up to 27,777,778 ordinary shares at a price of CAD 0.18 per Share, for gross proceeds of up to CAD 5,000,000.04 on November 3, 2025. The Offering is being completed pursuant to the Listed Issuer Financing Exemption, the Ordinary Shares issued pursuant to the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. The Company has also engaged Integrity Capital Group Inc. ("Integrity") to act as a finder in connection with the offering and may pay fees in accordance with the policies of the TSX Venture Exchange (the "Exchange"), being a cash commission of up to 6.0% plus 6% in Brokers Warrants, on total proceeds, received from subscribers introduced to the Company by Integrity. The Company may also pay certain reasonable expenses incurred by Integrity up to a maximum of CAD 10,000, exclusive of taxes. Closing is expected to occur on or before November 21, 2025. The Offering is subject to certain conditions, including, but not limited to, receipt of all necessary approvals, including the approval of the Exchange. 
